Neurodegenerative Drugs This report analyzes the worldwide markets for Neurodegenerative Drugs in US$ Million by the following disease types: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Other Neurodegenerative Diseases.... |
Novartis Pharma K.K.-Therapeutic Competitors Report Novartis Pharma K.K.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and... |
Anti-Migraine Drugs This report analyzes the US And European markets for Anti-Migraine Drugs in US$ Million. Annual forecasts are provided for the period 2006 through 2015. A six-year historic Analysis is also... |
Psoriasis Drugs This report analyzes the worldwide markets for Psoriasis Drugs in US$ Million by the following Drug Administration Routes - Systemic Drugs, and Topical Drugs. The report provides separate comprehensive analytics... |
Product Profiles: Osteoporosis Novel candidates offer the greatest potential Introduction
Despite major brands losing market exclusivity increasing cost competition, the osteoporosis market remains attractive. Leading osteoporosis companies continue to promote their products and develop their franchises while drug developers strive... |
Inflammatory Bowel Disease Therapeutics This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles... |
Global Pharma-biotech Alliance Analysis This IBD provides an overview of the pharma-biotech alliance deals struck from 2008 to present. This study covers deal structures by therapeutic area, stage of product development and deal type.... |
Analgesics This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments:
Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics.
The report provides separate... |
Pulmonary Drug Delivery Technologies This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in US$ Million by the following Product Segments: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Others. The... |
Pharmaceutical Market Trends, 2010 - 2014 Key market forecasts & growth opportunities (4th Edition) Pharmaceutical
Market Trends, 2010 - 2014:
Key market forecasts & growth opportunities presents a detailed trend analysis of
the global pharmaceutical market to the end of 2009 and forecasts until 2014.
This 142 page... |
Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape Introduction
With sales growth rates expected to fall below their historic levels, Big Pharma must act to bolster its performance out to 2012 if it is to maintain the investment community's... |
Multiple Sclerosis Therapeutics This report analyzes the worldwide markets for Multiple Sclerosis Therapeutics in US$ Billion. The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual estimates... |
Deal Making Spotlight on Novartis Spotlight Report Series During 2005, seven of the top ten licensing or co-development deals (in terms of total potential value) involved one of the five companies featured in the Spotlight Reports big pharma... |
Tuberculosis Therapeutics This report analyzes the Global market for Tuberculosis Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including... |
Anti-Hypertensive Drugs This report analyzes the worldwide markets for Anti-Hypertensive Drugs in US$ Million. The report provides separate comprehensive analytics for US, Europe and Rest of World. Annual forecasts are provided... |
ADHD Therapeutics This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US and Rest of World. Annual estimates and forecasts... |
Ukraine Pharma - New Opportunities for Growth According to Ukraine Pharma - New Opportunities for Growth, a new research report by RNCOS, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In... |
Novartis AG: PharmaVitae Profile This analysis examines the historical and forecast performance for Novartis in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance,... |
Cystic Fibrosis This report analyzes the US market for Cystic Fibrosis in Millions of US$. Annual estimates and forecasts are provided for the period of 2007 through 2015. Also, a six-year historic... |
Infectious Diseases Vaccine Market Overview Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeth's Prevnar... |
Cardiovascular Drugs This report analyzes the worldwide markets for Cardiovascular Drugs in US$ Million. Cardiovascular diseases can be prevented or treated using different classes of drugs. Broadly, the major classes of cardiovascular... |
Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights "Among The 23 New Pharmaceutical Products Approved In The First Half Of 2007, There Were 22 Small Molecule Pharmaceutical Drugs And One Monoclonal Antibody."
Pharmaceutical Product Approval Trends 2007: Key Market... |
US Pharmaceutical Market Outlook 2011-2021 Do you want to know the effects of the Obama government's legislation for US healthcare? Insurance coverage will be extended, expanding the pharma market. But at what price to the... |